Article:Yoel Shoshan, Moshiko Raboh, Michal Ozery-Flato, et al.
MAMMAL: Multi-Modal Foundation Model for Biomedical Discovery
Researchers from IBM and collaborating institutions introduce MAMMAL, a cross-modal foundation model tailored to drug discovery. The architecture unifies protein and antibody sequences, small molecules, and gene expression profiles into a sequence-based framework, pre-trained on two billion samples.